192 related articles for article (PubMed ID: 33434352)
1. Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID-19 pandemic.
Patel S; Thompson MD; Slaven JE; Sanders DB; Ren CL
Pediatr Pulmonol; 2021 May; 56(5):1271-1273. PubMed ID: 33434352
[TBL] [Abstract][Full Text] [Related]
2. Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study.
Somayaji R; Goss CH; Khan U; Neradilek M; Neuzil KM; Ortiz JR
Clin Infect Dis; 2017 Jun; 64(12):1760-1767. PubMed ID: 28329304
[TBL] [Abstract][Full Text] [Related]
3. Effect of the COVID-19 pandemic on anxiety among children with cystic fibrosis and their mothers.
Pınar Senkalfa B; Sismanlar Eyuboglu T; Aslan AT; Ramaslı Gursoy T; Soysal AS; Yapar D; İlhan MN
Pediatr Pulmonol; 2020 Aug; 55(8):2128-2134. PubMed ID: 32530552
[TBL] [Abstract][Full Text] [Related]
4. Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India.
Arvind B; Medigeshi GR; Kapil A; Xess I; Singh U; Lodha R; Kabra SK
Indian J Med Res; 2020 Jan; 151(1):65-70. PubMed ID: 32134016
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
[TBL] [Abstract][Full Text] [Related]
6. Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.
Davis CS; Faino AV; Onchiri F; Gibson RL; Merjaneh L; Ramsey BW; Rosenfeld M; Cogen JD
Ann Am Thorac Soc; 2023 Jan; 20(1):75-82. PubMed ID: 36044723
[No Abstract] [Full Text] [Related]
7. Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic.
Mathew HR; Choi MY; Parkins MD; Fritzler MJ
BMC Pulm Med; 2021 May; 21(1):173. PubMed ID: 34016096
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment.
Cogen JD; Sanders DB; Slaven JE; Faino AV; Somayaji R; Gibson RL; Hoffman LR; Ren CL
Ann Am Thorac Soc; 2023 Sep; 20(9):1293-1298. PubMed ID: 37327485
[No Abstract] [Full Text] [Related]
9. Poor Respiratory Health Following Relapsing SARS-CoV-2 Infection in Children with Cystic Fibrosis.
Dhochak N; Jat KR; Soni KD; Singh Y; Aggarwal R; Lodha R; Trikha A; Kabra SK
Indian J Pediatr; 2022 Apr; 89(4):404-406. PubMed ID: 35089489
[TBL] [Abstract][Full Text] [Related]
10. Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis.
VanDevanter DR; Pasta DJ; Konstan MW
J Cyst Fibros; 2015 Nov; 14(6):763-9. PubMed ID: 25754096
[TBL] [Abstract][Full Text] [Related]
11. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.
Mondejar-Lopez P; Quintana-Gallego E; Giron-Moreno RM; Cortell-Aznar I; Ruiz de Valbuena-Maiz M; Diab-Caceres L; Prados-Sanchez C; Alvarez-Fernandez A; Garcia-Marcos PW; Peñalver-Mellado C; Pastor-Vivero MD; Olveira C; Lopez-Neyra A; Castillo-Corullon S; Palma-Milla S; Perez-Ruiz E; Sole-Jover A; Barrio MI; Sanchez-Solis M; Asensio de la Cruz Ó;
Respir Med; 2020; 170():106062. PubMed ID: 32843180
[TBL] [Abstract][Full Text] [Related]
12. Clinical features associated with pulmonary exacerbation diagnosis in infants and young children with cystic fibrosis.
Corcoran A; Faig W; Ren CL
Pediatr Pulmonol; 2024 Apr; 59(4):874-879. PubMed ID: 38131505
[TBL] [Abstract][Full Text] [Related]
13. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and Management of Cystic Fibrosis Exacerbations.
Milinic T; McElvaney OJ; Goss CH
Semin Respir Crit Care Med; 2023 Apr; 44(2):225-241. PubMed ID: 36746183
[TBL] [Abstract][Full Text] [Related]
15. Course of Illness after Viral Infection in Indian Children with Cystic Fibrosis.
Gulla KM; Balaji A; Mukherjee A; Jat KR; Sankar J; Lodha R; Kabra SK
J Trop Pediatr; 2019 Apr; 65(2):176-182. PubMed ID: 29893951
[TBL] [Abstract][Full Text] [Related]
16. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
17. Association between serum 25-hydroxyvitamin D level and pulmonary exacerbations in cystic fibrosis.
Vanstone MB; Egan ME; Zhang JH; Carpenter TO
Pediatr Pulmonol; 2015 May; 50(5):441-6. PubMed ID: 25657016
[TBL] [Abstract][Full Text] [Related]
18. Measuring recovery in health-related quality of life during and after pulmonary exacerbations in patients with cystic fibrosis.
Flume PA; Suthoff ED; Kosinski M; Marigowda G; Quittner AL
J Cyst Fibros; 2019 Sep; 18(5):737-742. PubMed ID: 30587335
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations.
Thornton CS; Caverly LJ; Kalikin LM; Carmody LA; McClellan S; LeBar W; Sanders DB; West NE; Goss CH; Flume PA; Heltshe SL; VanDevanter DR; LiPuma JJ
Ann Am Thorac Soc; 2024 Apr; 21(4):595-603. PubMed ID: 37963297
[No Abstract] [Full Text] [Related]
20. The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation.
Caverly LJ; VanDevanter DR
J Pediatric Infect Dis Soc; 2022 Sep; 11(Supplement_2):S40-S45. PubMed ID: 36069900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
